UNITY Biotechnology (UBX) Misses Q3 EPS by 16c

UNITY Biotechnology (NASDAQ: UBX) reported Q3 EPS of ($1.05), $0.16 worse than the analyst estimate of ($0.89).

For earnings history and earnings-related data on UNITY Biotechnology (UBX) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Indosat Tbk PT (ISAT:IJ) (PTITF) PT Raised to IDR35.10 at JPMorgan
• Endava CFO placed on leave amid accounting probe